Jin10 data reported on October 10, Hahantong announced,
The company's stock closing price has deviated by more than 30% over two consecutive trading days, which is classified as an abnormal fluctuation in stock trading. Recently, the company has noticed public media reports regarding the application of the company's products in controlled nuclear fusion projects.
The company's products can be used for controlled nuclear fusion projects, but currently, the revenue from products used for controlled nuclear fusion accounts for less than 1% of total revenue. We urge all investors to invest cautiously and to be aware of investment risks.
View Original
LlllllllllllGateniubility
MC:$5.62KHolders:1
0.00%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Jin10 data reported on October 10, Hahantong announced,
The company's stock closing price has deviated by more than 30% over two consecutive trading days, which is classified as an abnormal fluctuation in stock trading. Recently, the company has noticed public media reports regarding the application of the company's products in controlled nuclear fusion projects.
The company's products can be used for controlled nuclear fusion projects, but currently, the revenue from products used for controlled nuclear fusion accounts for less than 1% of total revenue. We urge all investors to invest cautiously and to be aware of investment risks.